United States Food and Drug Administration Drug Approval SummaryMartin H. Cohen, Richard Pazdur, Sophia Abraham et al.|Clinical Cancer Research|2004Cited by 500
Approval Summary: Sunitinib for the Treatment of Imatinib Refractory or Intolerant Gastrointestinal Stromal Tumors and Advanced Renal Cell CarcinomaVicki Goodman, Richard Pazdur, Edwin P. Rock et al.|Clinical Cancer Research|2007Cited by 495
Approval Summary: Azacitidine for Treatment of Myelodysplastic Syndrome SubtypesEdvardas Kaminskas, Richard Pazdur, Yongcheng Wang et al.|Clinical Cancer Research|2005Cited by 424